UCSF/Zuckerberg San Francisco General Hospital and Trauma Center

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States	Chemically-Induced Disorders, Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol-induced disorders, alcohol-related disorders, alcoholic liver cirrhosis, alcoholic liver disease, cirrhosis of liver, fatty liver disease, liver disorder, metabolic dysfunction-associated steatotic liver disease, substance-related disorder	Recruiting	Phase 2	2026-09-28		NCT05832229
Liver Cirrhosis Network Cohort Study	Chemically-Induced Disorders, Cirrhosis, Cryptogenic, Digestive System Diseases, Fibrosis, Hepatitis, Chronic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol-induced disorders, alcohol-related disorders, alcoholic liver cirrhosis, alcoholic liver disease, autoimmune disease, autoimmune hepatitis, bile duct disorder, biliary tract disorder, cholestasis, cirrhosis of liver, fatty liver disease, hepatitis, immune system disorder, intrahepatic cholestasis, liver disorder, metabolic dysfunction-associated steatotic liver disease, primary biliary cholangitis, substance-related disorder	Active, not recruiting	Not stated	2026-01-13		NCT05740358

Clinical trials